Abeja Christine Joy, Niyonzima Vallence, Byagamy John Paul, Obua Celestino
Department of Nursing and Midwifery, Lira University, Lira, Uganda.
Department of Nursing, Mbarara University of Science and Technology, Mbarara, Uganda.
Pneumonia (Nathan). 2022 Apr 25;14(1):3. doi: 10.1186/s41479-022-00095-0.
Pneumonia is a major cause of morbidity and mortality in children under five. Antibiotic treatment must be started immediately in children with pneumonia. The irrational use of antibiotics may increase morbidity and mortality in children with pneumonia. Pneumonia accounted for approximately 16% of the 5.6 million under-five deaths word wide in 2016. In Uganda, it kills approximately 2,400 children per year. Early diagnosis and appropriate case management with rational use of antibiotics remain the most effective intervention to reduce pneumonia-related mortality. This study aimed at determining antibiotic prescription rationality and associated in-patient treatment outcomes in children aged 2-59 months with severe community-acquired pneumonia at Bwizibwera Health Centre IV from 1 May 2018 to 30 April 2019.
We conducted a retrospective cohort study design; data were collected from in-patient records of all children aged 2-59 months with severe community-acquired pneumonia who met the eligibility criteria for a period of one year. Data abstraction template was used for data collection. Health care records of children aged 2-59 months who had other co-morbidities and were on medication that could influence or impact on in-patient treatment outcomes from 1st May 2018 to 30th April 2019 were excluded. Data was entered and analyzed using Epi-info v 7.2 and STATA v 13.0 respectively, Descriptive statistics were reported and Chi-square test was used to compare the proportions.
Of the total records of children retrieved and screened (N = 847), 229 prescription records of children fulfilled inclusion criteria, 57 (24.9%) had rational prescriptions with good outcomes and 172 (75.1%) had irrational prescriptions with 10 (4.4%) having unfavorable outcomes. The majority (73.7%) of those who received rational prescription were on treatment with a combination of benzyl penicillin plus gentamycin while (26.3%) were on ampicillin plus gentamycin. The majority (32.4%) of patients with good treatment outcomes were aged 6 - 11 months. This age category also doubled as the group that experienced the highest percentage (40.0%) of unfavorable outcomes. There were no statistically significant associations between patient characteristics and treatment outcomes.
In conclusion, the majority of children had irrational antibiotic prescriptions and 40 percent of children aged 6-11 Months had unfavorable treatment outcomes with 20 percent death. This study also found out that majority of antibiotic prescription among children under five was irrational and it's against Uganda clinical guideline for treatment of severe pneumonia among children under five.
肺炎是五岁以下儿童发病和死亡的主要原因。肺炎患儿必须立即开始抗生素治疗。抗生素的不合理使用可能会增加肺炎患儿的发病率和死亡率。2016年,肺炎导致全球560万五岁以下儿童死亡,约占16%。在乌干达,每年约有2400名儿童死于肺炎。早期诊断并合理使用抗生素进行恰当的病例管理,仍然是降低肺炎相关死亡率最有效的干预措施。本研究旨在确定2018年5月1日至2019年4月30日期间,布维齐韦拉四级健康中心2至59个月患有重症社区获得性肺炎儿童的抗生素处方合理性及相关住院治疗结果。
我们采用回顾性队列研究设计;从所有符合入选标准的2至59个月患有重症社区获得性肺炎儿童的住院记录中收集了为期一年的数据。使用数据提取模板进行数据收集。排除2018年5月1日至2019年4月30日期间患有其他合并症且正在使用可能影响住院治疗结果药物的2至59个月儿童的医疗记录。数据分别使用Epi-info v 7.2和STATA v 13.0录入和分析,报告描述性统计数据,并使用卡方检验比较比例。
在检索和筛选的儿童总记录(N = 847)中,229份儿童处方记录符合纳入标准,57份(24.9%)处方合理且治疗结果良好,172份(75.1%)处方不合理,其中10份(4.4%)治疗结果不佳。接受合理处方的大多数(73.7%)儿童使用苄青霉素加庆大霉素联合治疗,而(26.3%)使用氨苄青霉素加庆大霉素。治疗结果良好的患者大多数(32.4%)年龄在6至11个月。这个年龄组也是治疗结果不佳比例最高(40.0%)的组。患者特征与治疗结果之间无统计学显著关联。
总之,大多数儿童抗生素处方不合理,6至11个月儿童中有40%治疗结果不佳,其中20%死亡。本研究还发现五岁以下儿童的大多数抗生素处方不合理,这违反了乌干达五岁以下儿童重症肺炎治疗的临床指南。